An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)

A Alagheband Bahrami, A Azargoonjahromi… - Cellular & molecular …, 2022 - Springer
Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …

COVID-19 pandemic and vaccines update on challenges and resolutions

WH Khan, Z Hashmi, A Goel, R Ahmad… - Frontiers in cellular …, 2021 - frontiersin.org
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …

Advances in the design and development of SARS-CoV-2 vaccines

XL Peng, JSY Cheng, HL Gong, MD Yuan… - Military Medical …, 2021 - Springer
Since the end of 2019, coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA …

SARS-CoV-2 variants, current vaccines and therapeutic implications for COVID-19

HY Liang, Y Wu, V Yau, HX Yin, S Lowe, R Bentley… - Vaccines, 2022 - mdpi.com
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has caused hundreds of millions of infections, resulting in an unprecedented pandemic of …

Developmental landscape of potential vaccine candidates based on viral vector for prophylaxis of COVID-19

R Bezbaruah, P Borah, BB Kakoti… - Frontiers in Molecular …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, arose at the end of 2019 as
a zoonotic virus, which is the causative agent of the novel coronavirus outbreak COVID-19 …

[HTML][HTML] COVID-19 vaccine: critical questions with complicated answers

MF Haidere, ZA Ratan, S Nowroz… - Biomolecules & …, 2021 - ncbi.nlm.nih.gov
COVID-19 has caused extensive human casualties with significant economic impacts
around the globe, and has imposed new challenges on health systems worldwide. Over the …

Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2

N Firouzabadi, P Ghasemiyeh, F Moradishooli… - International …, 2023 - Elsevier
It has been more than three years since the first emergence of coronavirus disease 2019
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …

[HTML][HTML] COVID-19 challenges and its therapeutics

SU Rehman, SU Rehman, HH Yoo - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …

Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update

U Anand, S Jakhmola, O Indari, HC Jha… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …